KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer

Abstract: Most clinical PARP inhibitors (PARPis) trap PARP1 in a chromatin‐bound state, leading to PARPi‐mediated cytotoxicity. PARPi resistance impedes the treatment of ovarian cancer in clinical practice. However, the mechanism by which cancer cells overcome PARP1 trapping to develop PARPi resistance remains unclear. Here, it is shown that high levels of KAT6A promote PARPi resistance in ovarian cancer, regardless of its catalytic activity. Mechanistically, the liquid‐liquid phase separation (LLPS) of KAT6A, facilitated by APEX1, inhibits the cytotoxic effects of PARP1 trapping during PARPi treatment. The stable KAT6A‐PARP1‐APEX1 complex reduces the amount of PARP1 trapped at the DNA break sites. In addition, inhibition of KAT6A LLPS, rather than its catalytic activity, impairs DNA damage repair and restores PARPi sensitivity in ovarian cancer both in vivo and in vitro. In conclusion, the findings demonstrate the role of KAT6A LLPS in fostering PARPi resistance and suggest that repressing KAT6A LLPS can be a potential therapeutic strategy for PARPi‐resistant ovarian cancer.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer ; day:08 ; month:07 ; year:2024 ; extent:17
Advanced science ; (08.07.2024) (gesamt 17)

Creator
Zhan, Zhiyan
Zhang, Jiarong
Liang, Huisheng
Wang, Chong
Hong, Li
Liu, Wenxue

DOI
10.1002/advs.202400140
URN
urn:nbn:de:101:1-2407091435545.915242119835
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Zhan, Zhiyan
  • Zhang, Jiarong
  • Liang, Huisheng
  • Wang, Chong
  • Hong, Li
  • Liu, Wenxue

Other Objects (12)